Articles with "dex implant" as a keyword



Photo from wikipedia

Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion

Sign Up to like & get
recommendations!
Published in 2021 at "Graefe's Archive for Clinical and Experimental Ophthalmology"

DOI: 10.1007/s00417-021-05146-8

Abstract: To investigate the long-time outcome of patients with branch vein occlusion (BRVO) and central vein occlusion (CRVO) treated with anti-VEGF injections compared to the dexamethasone (DEX) implant. This retrospective real-life study included all 492 patients… read more here.

Keywords: anti vegf; vegf; vein occlusion; patients treated ... See more keywords

Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study

Sign Up to like & get
recommendations!
Published in 2022 at "Eye"

DOI: 10.1038/s41433-022-01931-9

Abstract: We aimed to compare visual and anatomical outcome in vitrectomized and non-vitrectomized eyes treated with dexamethasone (DEX) implant due to diabetic macular oedema (DMO). Multicenter, retrospective, interventional study. 236 eyes from 234 patients with DMO… read more here.

Keywords: difference; vitrectomized eyes; non vitrectomized; dex implant ... See more keywords
Photo from wikipedia

[Clinical Decision Making for Treatment of Diabetic Macular Oedema with DEX Implant: a Consensus Paper].

Sign Up to like & get
recommendations!
Published in 2019 at "Klinische Monatsblatter fur Augenheilkunde"

DOI: 10.1055/a-1024-4089

Abstract: BACKGROUND Currently two intravitreally applied corticosteroids (dexamethasone and fluocinolone) are licensed in Germany for treatment of diabetic macular oedema (DME). The use of DEX implant for DME in daily clinical practice has not been defined… read more here.

Keywords: dex; dex implant; treatment; consensus ... See more keywords
Photo from wikipedia

Treatment of diabetic macular edema with intravitreal DEX Implant in Germany: Efficacy and safety in naïve and pre-treated patients in clinical practice.

Sign Up to like & get
recommendations!
Published in 2022 at "European journal of ophthalmology"

DOI: 10.1177/11206721221076697

Abstract: PURPOSE To investigate the efficacy and safety of dexamethasone (DEX) implant in eyes with diabetic macular edema (DME) over 12-months. METHODS In this retrospective study charts from a single center were analysed, including naïve and… read more here.

Keywords: group; dex implant; pre treated; treated patients ... See more keywords
Photo from wikipedia

Expert recommendations for the management of diabetic macular edema with intravitreal dexamethasone implant: A Turkish Delphi study

Sign Up to like & get
recommendations!
Published in 2022 at "European Journal of Ophthalmology"

DOI: 10.1177/11206721221117695

Abstract: Purpose To provide consensus on the clinical use of intravitreal dexamethasone (DEX) implant for the treatment of diabetic macular edema (DME) in Turkey. Methods A panel of 22 retina experts prepared 77 statements of recommendation,… read more here.

Keywords: consensus; macular edema; intravitreal dexamethasone; dex implant ... See more keywords
Photo from wikipedia

Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India

Sign Up to like & get
recommendations!
Published in 2020 at "BMC Ophthalmology"

DOI: 10.1186/s12886-020-01630-7

Abstract: Background Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. As India has the second largest population of diabetic patients worldwide, availability of various treatment options for DME is… read more here.

Keywords: visual impairment; dex; dex implant; treatment ... See more keywords
Photo from wikipedia

Widening use of dexamethasone implant for the treatment of macular edema

Sign Up to like & get
recommendations!
Published in 2017 at "Drug Design, Development and Therapy"

DOI: 10.2147/dddt.s138922

Abstract: Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is… read more here.

Keywords: use; dex implant; treatment; edema ... See more keywords